Nathan Tague

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Candida Albicans

Top Venues

ACS chemical biology

ACS synthetic biology

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop
Light-inducible protein degradation in E. coli with the LOVdeg tag. eLife 12 (2024)
Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop
Light-inducible protein degradation in E. coli with the LOVdeg tag. eLife 12 (2024)
Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop
Light-inducible protein degradation in E. coli with the LOVdeg tag. eLife 12 (2024)
Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop
Light-inducible protein degradation in E. coli with the LOVdeg tag. eLife 12 (2024)
Nathan Tague, Cristian Coriano-Ortiz, Michael B Sheets, Mary J Dunlop
Light-inducible protein degradation in E. coli with the LOVdeg tag. eLife 12 (2024)
Nathan Tague, Virgile Andreani, Yunfan Fan, Winston Timp, Mary J Dunlop
Comprehensive Screening of a Light-Inducible Split Cre Recombinase with Domain Insertion Profiling. ACS synthetic biology (2023)
Elliot P Tague, Jeffrey B McMahan, Nathan Tague, Mary J Dunlop, John T Ngo
Controlled Protein Activities with Viral Proteases, Antiviral Peptides, and Antiviral Drugs. ACS chemical biology 18 (5) (2023)
Elliot P Tague, Jeffrey B McMahan, Nathan Tague, Mary J Dunlop, John T Ngo
Controlled Protein Activities with Viral Proteases, Antiviral Peptides, and Antiviral Drugs. ACS chemical biology 18 (5) (2023)
Elliot P Tague, Jeffrey B McMahan, Nathan Tague, Mary J Dunlop, John T Ngo
Controlled Protein Activities with Viral Proteases, Antiviral Peptides, and Antiviral Drugs. ACS chemical biology (2023)
Elliot P Tague, Jeffrey B McMahan, Nathan Tague, Mary J Dunlop, John T Ngo
Controlled Protein Activities with Viral Proteases, Antiviral Peptides, and Antiviral Drugs. ACS chemical biology 18 (5) (2023)